StockData
Bicycle Therapeutics PLC logo

Bicycle Therapeutics PLC (BCYC) stock

BCYCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 11/3080% below fair value
$3.20+0.02 (+0.63%)

Close on Nov 17, 2026Market cap $224.30MP/E –Yield 0.00%

Bicycle Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Bicycle Therapeutics's market cap was $257.61M on Nov 11, 2026, against $518.41M a year earlier. Over the last 5 years it ranged from $255.52M to $1.62B, with a median of $690.04M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$257.61M-47.5%
2025Dec 31, 2025$490.69M-49.2%
2024Dec 31, 2024$966.22M+26.1%
2023Dec 29, 2023$766.32M-12.8%
2022Dec 30, 2022$878.48M-43.6%
2021Dec 31, 2021$1.56B+314.6%
2020Dec 31, 2020$375.80M+122.6%
2019Dec 31, 2019$168.82M–

More Bicycle Therapeutics figures

See a number that looks wrong?